Adam Laponis is Chief Financial Officer of Twist Bioscience Corp. Currently has a direct ownership of 73,397 shares of TWST, which is worth approximately $2.96 Million. The most recent transaction as insider was on Oct 09, 2024, when has been sold 856 shares (Common Stock) at a price of $41.81 per share, resulting in proceeds of $35,789. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.4K
0.28% 3M change
n/a 12M change
Total Value Held $2.96 Million

Adam Laponis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2024
SELL
Open market or private sale
$35,789 $41.81 p/Share
856 Reduced 1.15%
73,397 Common Stock
Jul 09 2024
SELL
Open market or private sale
$41,182 $48.91 p/Share
842 Reduced 1.13%
73,602 Common Stock
Apr 09 2024
SELL
Open market or private sale
$18,436 $33.16 p/Share
556 Reduced 0.74%
74,444 Common Stock
Jan 08 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock

Also insider at

EAR
Eargo, Inc. Healthcare
AL

Adam Laponis

Chief Financial Officer
San Jose, CA

Track Institutional and Insider Activities on TWST

Follow Twist Bioscience Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST